Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Syndax Pharmaceuticals (SNDX) Receivables - Net: 2024-2025

Historic Receivables - Net for Syndax Pharmaceuticals (SNDX) over the last 1 years, with Sep 2025 value amounting to $25.4 million.

  • Syndax Pharmaceuticals' Receivables - Net was N/A to $25.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.4 million, marking a year-over-year change of. This contributed to the annual value of $7.6 million for FY2024, which is N/A change from last year.
  • Per Syndax Pharmaceuticals' latest filing, its Receivables - Net stood at $25.4 million for Q3 2025, which was up 30.58% from $19.5 million recorded in Q2 2025.
  • Syndax Pharmaceuticals' Receivables - Net's 5-year high stood at $25.4 million during Q3 2025, with a 5-year trough of $7.6 million in Q4 2024.
  • For the 2-year period, Syndax Pharmaceuticals' Receivables - Net averaged around $17.0 million, with its median value being $17.6 million (2025).